infertility. Female infertility associated with anovulation
Conditions
Interventions
Intervention 1: Intervention group: In addition to routine treatment (gonadotropin), one 0.5 dexamethasone tablet Aburaihan company is prescribed oral every 12 hours from the third day of the cycle u
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Every PCO patient (20-40 years old) based on the Rotterdam criteria, who has a history of infertility for tow year normal PRL and TSH no underlying heart, liver, or kidney disease BMI between 18-30
Exclusion criteria
Exclusion criteria: women with one ovary uterine problems such as fibroids, septum history of ovarian surgery endometrioma male factor infertility
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number and size of follicles after drug administration. Timepoint: The day of the cycle start, the day of starting gonadotropins, and also the day of GNRH antagonist administration. Method of measurement: Ultrasound. | — |
Secondary
| Measure | Time frame |
|---|---|
| Endometrial Thickness. Timepoint: The day of the cycle start, the day of starting gonadotropins, and also the day of GNRH antagonist administration. Method of measurement: Ultrasound. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaliheh Afiat
Mashhad University of Medical Sciences
Outcome results
None listed